Skip to main content
Premium Trial:

Request an Annual Quote

Orchid BioSciences Q2 Revenues Rise

NEW YORK, July 29 (GenomeWeb News) - Orchid BioSciences today reported second quarter revenues of $15 million, a significant gain on its 2003 second quarter revenues of $12.4 million.


The Princeton, N.J.-based firm said that its service revenues climbed to $14.8 million from $12.2 million in the comparable quarter a year ago. The firm attributed the revenue growth to an increase in testing volume.


Orchid reported a net loss for the quarter of $1.8 million, or $.08 per share, compared to a net loss of $5.5 million, or $.55 per share, in the second quarter a year ago.


Orchid, which provides genetic testing services for the paternity, forensics, and food safety markets, finished the quarter with $31.1 million in cash and cash equivalents.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.